Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT vs FOSFOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAPREPITANT vs FOSFOMYCIN: Safety Overview

Metric FOSAPREPITANT FOSFOMYCIN
Total FAERS Reports 487 828
Deaths Reported 154 128
Death Rate 31.6% 15.5%
Hospitalizations 264 407
Average Patient Age 49.6 yrs 55.3 yrs
% Female Patients 83.0% 57.3%
FDA Approval Date N/A Oct 22, 2025
Manufacturer N/A Meitheal Pharmaceuticals Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription